Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1998-2-18
pubmed:abstractText
Ablation of the thyroid gland with radioactive iodine-I131 is an effective and safe method of therapy for older children and adolescents, as with adults, to treat hyperthyroidism of Graves disease (Graves-Basedow disease). The use of radioiodine as initial therapy or, as more often, the second line of therapy following antithyroid drug treatment is highly efficacious and rarely associated with short-term or long-term side effects. The indications for radioiodine therapy are failure of antithyroid drug therapy, idiosyncratic hypersensitivity reactions to antithyroid drugs, contraindications for surgical therapy including patients who refuse surgery, and the desirability to permanently prevent the development of hyperthyroidism. The treatment will induce permanent primary hypothyroidism within months after the use of ablative doses of radioiodine. The safety and simplicity of clinical management with L-thyroxine therapy for hypothyroidism favor radioiodine therapy for Graves disease over the potential risks from treatment with antithyroid drugs or surgery, and from untreated or relapsing hyperthyroidism. Radioiodine therapy is associated with the lowest morbidity and mortality among the currently available methods of therapy for Graves disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0947-7349
pubmed:author
pubmed:issnType
Print
pubmed:volume
105 Suppl 4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
61-5
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Radioiodine treatment of juvenile Graves disease.
pubmed:affiliation
Department of Pediatrics, School of Medicine, University of Pittsburgh, PA, USA. foleyt@chplink.chp.edu
pubmed:publicationType
Journal Article, Review